Novorêx · Applied Neurointelligence · About

Why Novorêx exists.

A cancer doctor’s question: what are we missing when we don’t hear the person?

Dr. Sam Sater MD in a white coat against a navy wall
Dr. Sam Sater MD, hematologist-oncologist and founder of Novorêx

Dr. Sam Sater MD · Hematologist-oncologist and physician-scientist

  • Board-certifiedAmerican Board of Internal Medicine: internal medicine, hematology and medical oncology
  • NCI · NIHPhysician-scientist and faculty, 2017–2021. Founded its Tumor Immune Microenvironment Laboratory
  • 30+ trialsContributed to clinical trials, Phase I–IV
  • 20+ yearsPatient care, cancer research and medical education
  • MENASA 2026Spoke at the 2nd MENASA Summit, Sugar Land, Texas, September 2026

Our line

Novorêx: humanizing AI to advance human maturation and intelligence. The human layer of care, led by a physician.

“I trained and practiced in some of medicine’s most demanding places. And still, one year, I could not tell who I was anymore. What helped me rebuild was not working harder. It was finally looking at the beliefs that had been driving me for decades. That experience is why Novorêx exists.”

Dr. Sam Sater MD

What we work on.

Access

Established

Where you live can change the care you get: how soon you are seen, how far you travel, what it costs.

Source: National Cancer Institute, “Cancer Disparities”

Novorêx is working toward care that is more equal, wherever people live.

Blind spots

Novorêx model

Each of us sees through our own reality. So do teams, clinics and health systems. Some of what we can’t see is harm built into how care is organized.

We design our education and tools to help people and organizations notice it, and talk about it.

The missing layer

Novorêx model

Beliefs, values and feelings shape how people live, lead and receive care.

This is the subject of The Missing Layer in Healing, the forthcoming book by Dr. Sam Sater MD.

Dr. Sam Sater MD

Founder of Novorêx · Founder and CEO, HAS Consulting LLC, which operates Novorêx

Dr. Sam Sater MD is a hematologist-oncologist and physician-scientist, board-certified by the American Board of Internal Medicine in internal medicine, hematology and medical oncology.

He has spent more than twenty years in patient care, cancer research and medical education.

From 2017 to 2021 he was a physician-scientist and faculty member at the National Cancer Institute (NIH), where he founded its Tumor Immune Microenvironment Laboratory. He has contributed to more than thirty clinical trials, from Phase I to Phase IV.

In the clinic he saw two people hear the same diagnosis and walk very different roads.

Novorêx is the result: Applied Neurointelligence, led by a physician, so that every person is heard. What Applied Neurointelligence means.

He continues to care for patients with cancer and blood disorders through Dr. Sater Boutique Clinic, a separate practice whose services are offered only at consultdrsater.com.

Selected publications and writing

  • Journal for ImmunoTherapy of Cancer · 2020 · First authorNeoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancerPublication record
  • American Heart Journal Plus · 2025 · Corresponding authorDiagnosis, clinical management, and emerging strategies for coronary artery disease in patients with cancerPublication record

Writing and commentary

Speaking and teaching

  • 2nd MENASA Summit, Sugar Land, Texas, 1 to 2 September 2026. Conference session title: “Next-Level Personalized Healthcare: Mental Health 2.0, Root-Cause Medicine & AI.”
Media and speaking

How we label what we say.

Established.

Accepted science, from peer-reviewed and replicated work.

Emerging.

Published, but early or limited. We say so.

Novorêx model.

Our own frameworks. Educational, not yet formally tested, and not diagnostic or treatment tools.

Start with the first chapter.

Novorêx is a trade name of HAS Consulting LLC. Novorêx Academy is its education arm. Clinical care with Dr. Sam Sater MD is provided by his clinic, separately from Novorêx.